2024 Symposium: Bringing it home... Embracing collective wisdom to grow our future
Symposium Co-Chairs: Prof Sallie Pearson and Dr Jack Janetzki
Previously we have 'bridged the gap between evidence and use' and 'mobilised data to accelerate evidence- generation'; we have learned from colleagues across the globe, and from consumers and policy makers.
As MI-CRE enters its fourth year, it's time to Bring it home...
This year's Annual Symposium held 14-15 August 2024 featured an exciting program of presentations and panel discussions from MI-CRE researchers, including for the first time, two special themed sessions showcasing consumer involvement and research impact.
As always, there was plenty of opportunity to network with friends and colleagues from across the MI-CRE nodes and our external stakeholders.
In keeping with this year's theme, we had two wonderful Keynote Speakers:
- Prof Andrew Wilson, Chair of the Pharmaceutical Benefits Advisory Committee (2015-2024) and MI-CRE Chief Investigator, who reflected on the role of pharmacoepidemiology in PBAC decision-making.
- Dr Andrea Schaffer, Epidemiologist, University of Oxford and UNSW alumna, who shared her experience working with the OpenSAFELY data analytics platform and the issues of balancing reproducibility and privacy when using real-world data.
On Day 2, we focused on building our science communication skills with a great workshop led by facilitator David Crisante and making plans for the next 12 months in our Portfolio Groups.
Links to the abstracts and recordings of the sessions can be found in the tabs below.
- Program Day 1
- Program Day 2
Ìý
Opening and WelcomeSymposium Co-Chairs: Dr Jack Janetzki and Prof Sallie Pearson |
|
---|---|
Contributions of pharmacoepidemiology to HTA - observations from PBAC 2015-2024 Keynote Speaker: Prof Andrew Wilson |
|
Abstract Session 1a: Consumer involvement stories Session Co-Chairs: Ms Ainslee Cahill and Mr Steven Marsh |
|
Ximena Camacho, UNSW Sydney |
Risk of injuries associated with initiation of tapentadol vs oxycodone. Ìý |
Nicola Meagher, Daffodil Centre |
‘Who is this for?’ Involving consumers in ovarian cancer research. |
Abstract Session 1b: Methods Session Chair: Prof Sallie Pearson |
|
Chrianna Bharat, NDARC UNSW Sydney |
The use and implementation of instrumental variables in pharmacoepidemiology: A scoping review |
Kelly Hall, University of South Australia |
Evaluation and extension of the prevalent new-user cohort design: A simulation study |
Abstract Session 2a: Pharmacoepi 'pot-pourri' Session Co-Chairs: Ms Kendal Chidwick and Dr Erin Kelty |
|
Tamara Milder, UNSW Sydney |
|
Ramya Padmavathy Radha Krishnan, University of Sydney |
|
Jun Ni Ho, University of South Australia |
|
Adrian Walker, UNSW Sydney |
|
Abstract Session 2b: CNS Medicines and Harms Session Co-Chairs: Ms Jun Ni Ho and Ms Ramya Padmavathy Radha Krishnan |
|
Craig Cumming, University of Western Australia | |
Ebony Quintrell, University of Western Australia | Alcohol pharmacotherapy dispensing trends in Australia between 2006 and 2023 |
Kendal Chidwick, NDARC UNSW Sydney | |
Ria Hopkins, NDARC UNSW Sydney | Age-related risk of serious fall events associated with opioid analgesic use |
Abstract Session 2c: Impact Stories Session Co-Chairs: Ms Kelly Hall and Dr Michael Falster |
|
Erin Kelty, University of Western Australia | Big pharma, big impact? – The safety of methoxyflurane for emergency pain relief |
Lachlan Dalli, Monash University | |
Jack Janetzki, University of South Australia | |
Laura Gerhardy, University of Sydney | Prescription retinoid and contraception use in women in Australia: getting the message out. |
MI-CRE Project Incubator Session Chair: Dr Chrianna Bharat |
|
Balancing reproducibility and privacy with real-world data: Lessons from OpenSAFELY Keynote Speaker: Dr Andrea Schaffer |
|
Awards Ceremony Session Co-Chairs: Prof Nicole Pratt and Dr Chrianna Bharat Wrap Up - Prof David Henry |
Ìý
Please note there are no recordings from our program on Day 2. |
Science Communication Workshop Facilitated by David Crisante |
Portfolio meetings |
'Minute with a Mentor' |
Project and Portfolio updatesÌý |
Team activity ECRs vs Cls - Translate that abstract! |
Closing remarks and wrap-up |